Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
Condition(s):Malignant Solid Tumor – Malignant Nervous System NeoplasmLast Updated:August 12, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Malignant Solid Tumor – Malignant Nervous System NeoplasmLast Updated:August 12, 2016Completed
Condition(s):Cancer of the Prostate; Metastatic CancerLast Updated:June 13, 2022Completed
Condition(s):Prostate CancerLast Updated:March 27, 2024Completed
Condition(s):HER2 Negative Metastatic Breast CancerLast Updated:November 13, 2019Recruiting
Condition(s):Castrate-resistant Metastatic Prostate CancerLast Updated:October 16, 2013Withdrawn
Condition(s):Ovarian CancerLast Updated:October 8, 2020Completed
Condition(s):Brain Metastasis; Breast Cancer; Non Small Cell Lung CancerLast Updated:July 24, 2014Withdrawn
Condition(s):Advanced Prostate CancerLast Updated:February 11, 2016Withdrawn
Condition(s):Breast Cancer; Lung Cancer; Recurrent Brain Metastases; Progressive Brain MetastasesLast Updated:January 23, 2018Terminated
Condition(s):Non-seminomatous Germ-cell TumorsLast Updated:June 9, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.